http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006010493-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d1596f64ec0b2dac5334b2cf05b88bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d37eb461745b8d691065349d29825942 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e04826845acea4cc4cdeafc4c2b1e313 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0ef5c3365be7092a20772a4b3afd553 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 2005-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35b19e9441da08f9fcc91a2d148c9174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52a815d120d18a69d36ef9c4ce44e8b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36b9192f647409ae2db8f2c99d6e559d |
| publicationDate | 2006-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2006010493-A1 |
| titleOfInvention | Diagnostics and therapeutics for diseases associated with ethanolamine kinase 1 (ek11) |
| abstract | Diagnostics and Therapeutics for Diseases Associated with Ethanolamine Kinase 1 (EKI1) The invention provides a human EKII which is associated with cardiovascular diseases, infections, respiratory diseases, dermatological diseases, endocrinological diseases, metabolic diseases, gastroenterological diseases, cancer, inflammation, hematological diseases, muscle skeleton diseases, neurological diseases, urological diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular diseases, infections, respiratory diseases, dermatological diseases, endocrinological diseases, metabolic diseases, gastroenterological diseases, cancer, inflammation, hematological diseases, muscle skeleton diseases, neurological diseases, urological diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of EKI1 as well as pharmaceutical compositions comprising such compounds. |
| priorityDate | 2004-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 229.